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1A1
The accuracy of a diagnostic test or combination of tests (such
as in a diagnostic model) is the ability to correctly identify
patients with or without the target disease. In studies of
diagnostic accuracy, the results of the test or model under study
are verified by comparing them with results of a reference
standard, applied to the same patients, to verify disease status
(see first panel in figure).1 Measures such as predictive values,
post-test probabilities, ROC (receiver operating characteristics)
curves, sensitivity, specificity, likelihood ratios, and odds ratios
express how well the results of an index test agree with the
outcome of the reference standard.2 Biased and exaggerated
estimates of diagnostic accuracy can lead to inefficiencies in
diagnostic testing in practice, unnecessary costs, and physicians
making incorrect treatment decisions.
The reference standard ideally provides error-free classification
of the disease outcome presence or absence. In some cases, it
is not possible to verify the definitive presence or absence of
disease in all patients with the (single) reference standard, which
may result in bias. In this paper, we describe the most important
types of disease verification problems using examples from
published diagnostic accuracy studies.We also propose solutions
to alleviate the associated biases.
Partial verification
Often not all study subjects who undergo the index test receive
the reference standard, leading to missing data on disease
outcome (see middle panel in figure). The bias associated with
such situations of partial verification is known as partial
verification bias, work-up bias, or referral bias.3-5
Clinical examples of partial verification
Various mechanisms can lead to partial verification (see
examples in table 1).
When the condition of interest produces lesions that need biopsy
and subsequent histological verification (as in many cancers),
it is impossible to verify negative index test results (“where to
biopsy?”). An example is F-18 fluorodeoxyglucose positron
emission tomography (FDG-PET) to detect possible distant
metastases before planning curative surgery in patients with
carcinoma of the oesophagus: only the hotspots detected by
PET can be sampled by biopsy and verified histologically.6
Ethical reasons can also play a role in withholding a reference
standard. Angiography is still considered the best method for
detecting pulmonary embolisms, but, because of its invasiveness
and risk of serious complications, it is now considered unethical
to perform this reference standard in low risk patients, such as
those with a low clinical probability and negative D-dimer
result.10
Sometimes the reference standard may be temporarily
unavailable, or patients and doctors may decide to refrain from
disease verification. In a study evaluating the accuracy of digital
rectal examination and prostate specific antigen (PSA) for the
early detection of prostate cancer, 145 out of 1000men fulfilled
the criterion for verification by the reference standard
(transrectal ultrasound combined with biopsy). However, 54 of
these men did not undergo the reference standard, for unknown
reasons.7 In another study the accuracy of dobutamine-atropine
stress echocardiography for the diagnosis of coronary artery
disease was assessed, with coronary angiography as the
reference.8 Only a small proportion of patients received this
reference standard because the clinicians’ decision to refer to
angiography depended on the patient’s history and test results.
Potential for bias
The above examples show that partial disease verification, and
thus missing disease outcome status in some of the patients, is
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often not completely at random or non-selective. It is usually
based on results of the index test under study or other observed
patient variables or test results. If so, the missing outcome status
is selectively missing, as the reason for disease verification is
associated with other information. For example, patients with
a positive index test result or with a high clinical suspicion based
on other variables (that is, high probability before the index
test) are often more likely to be verified by the reference test
than patients with negative test results or a low probability
before the index test. Simply leaving such selectively unverified
patients out of the analysis will leave a non-random (selective)
part of the original group for analysis and thus generate biased
estimates of the accuracy of the index test under study.
The direction and size of this bias will depend on how selective
the reason for non-verification is, the number of patients whose
results are not verified, and the ratio between the number of
patients with positive and negative index test results that remain
unverified.5 The bias always occurs in the estimates of the
sensitivity and specificity of the diagnostic index test or model
under study, and often also in the predictive value. When the
reason for partially missing outcomes is based only on the results
of the index test, the predictive values of this index test will
indeed be unbiased (see below). If, however, the reason for
referral for reference testing is not only due to the index test
results but also to other patient information, the predictive values
of the index test will be affected.15
Corrections for partial verification bias
One of the early methods to correct for partial verification bias
was developed by Begg and Greenes.16Briefly, this method uses
only the pattern of disease and non-disease verified by the
reference standard among the patients with a positive or negative
result of the (single) index test under study. This pattern is then
used to calculate the expected number of diseased and
non-diseased among the non-verified patients with a positive
or negative index test result to obtain an inflated 2×2 table as
if all patients were verified by the reference standard. This
correction method assumes that the reason for referral to the
reference test is only due to the result of the index test under
study. Hence, conditional on these index test results, the decision
to verify is in fact a random process. The method can also be
extended to more than one test result, but this requires exact
knowledge of the reasons and patterns behind the partial
verification.16 17
More recently, multiple imputationmethods have been proposed
to correct for partial verification problems.18 19 Multiple
imputation can be viewed as a “statistical” workout of the
intuitive “diagnostic reasoning” of the clinician. Just as a
clinician in practice decides whether to refer a patient for disease
verification by a (more invasive, burdensome, or costly)
reference standard based on all available patient information,
multiple imputation techniques also use all available information
of a patient—and that of similar patients—to estimate the most
likely value of the missing reference test result in non-verified
patients.
Imputationmethods comprise two phases—an imputation phase
where each missing reference test result is estimated and
imputed from all available patient information, and an analysis
phase where accuracy estimates of the diagnostic index test or
model are computed by standard procedures based on the now
completed dataset. Several imputation variants are available,
ranging from single imputation of missing reference test values
to multiple imputation.20 21 Instead of filling in a single value
for each missing value, as with single imputation, multiple
imputation procedures replace each missing value with a set of
plausible values to represent the uncertainty about the imputed
value. These multiple imputed datasets are then analysed, one
by one, again by standard procedures. The results from these
analyses are combined to produce accuracy estimates of the
diagnostic index test(s) or model and confidence intervals that
properly reflect the uncertainty due to missing values.20 21
For optimal application of multiple imputation techniques to
address partial verification, it is important for researchers to
collect as much detailed data as possible on study subjects that
could potentially drive the (selective) referral for reference
testing. The performance of the multiple imputation or other
correction methods will improve with more and better
information that may be involved in disease verification
decisions. The flexibility of the multiple imputation method
enables the incorporation of multiple pieces of observed patient
information, not only the results of the index test under study,
thereby increasing the likelihood of correctly imputing missing
reference test values in patients in whom the disease status was
selectively not verified.17-19
The discussed mathematical methods to correct for selectively
missing verification, and thus partial verification bias, make
use of observed (patient) information or variables. They assume
that the reasons for missing verification depend on the observed
information only. Clearly, this assumption cannot be tested with
the data at hand, since non-observed information is, by
definition, not available. If one expects selectively missing
reference test results as a result of unobserved information, there
are methods to perform additional (sensitivity) analysis to
quantify to what extent the diagnostic accuracy estimates of the
index test change under these situations.22 23
Differential verification
Another common approach in diagnostic accuracy studies is to
use an alternative, second best, reference test in those subjects
for whom the first, preferred reference test cannot or will not
be used (see third panel in figure). Although this seems a
clinically appealing and ethical approach, bias arises when the
results of the two reference tests are treated as interchangeable.
Both reference tests are, almost by definition, of different quality
in terms of classification of the target disease or may even define
the target disease differently.24 25 Hence, simply combining all
disease outcome data in a single analysis (table 2), as if both
reference tests are yielding the same disease outcomes, does
not reflect the “true” pattern of disease presence and absence.
Such an estimation of disease prevalence differs from what one
would have obtained if all subjects had undergone the preferred
reference standard. Consequently, all estimated measures of the
accuracy of the diagnostic index test or model will be biased.
This is called differential verification bias.3 4
When evaluating a new marker for acute appendicitis,
histopathology of the appendix is the preferred reference test,
but clinical follow-up is sometimes used as an alternative (for
example, if histopathology is considered too invasive).
Compared with histopathology, clinical follow-up is likely to
have a higher implicit threshold to detect appendicitis, so it will
label more patients as non-diseased (that is, no appendicitis).
Thus, these two reference tests define the target condition in a
different way. Histopathology might seem the preferred
reference test because it reveals even the smallest number of
inflamed cells, but one could argue that the more relevant
information for clinical practice is not whether the patient has
inflamed cells but whether the patient will recover without
intervention. This would make clinical follow-up the preferred
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reference, even though it would be unethical to adopt for all
subjects and to withhold surgery. This does mean that accuracy
estimates from a combination of histopathology and follow-up
will differ systematically from what one would have obtained
if all index test results had been verified by either clinical
follow-up or histology.
Because accuracy estimates of the new index test ignore the use
of different reference tests, they are also difficult to interpret.
In situations of differential verifications such as this, the results
should be corrected and reported separately for each reference
standard to provide informative and unbiased measures of
accuracy of the diagnostic index test or model. We illustrate
this with a clinical example from the recent literature.
Clinical example
In a recent study11 the elbow extension test (EET) was examined
for its accuracy in ruling out elbow fractures. The preferred
reference test was radiography. For unstated reasons (costs,
efficiency, or minimising radiation exposure), radiography was
planned in patients with a positive EET result whereas the
patients with a negative EET received a structured follow-up
assessment by telephone after 7–10 days to verify whether elbow
fracture was absent (the alternative reference test). Only patients
who met any of the pre-specified recall criteria were asked to
return to the emergency department for radiography. The rest
were considered not to have a clinically significant elbow
fracture. The resulting data are shown in table 3.
The authors reported overall estimates of accuracy of the EET,
ignoring the use of different reference standards (table 4, first
row). Though both radiography and structured follow-up are
useful verification methods, their results are not necessarily
interchangeable.
The availability of 181 patients with a negative EET who were,
after all, evaluated by radiography (“protocol violations” in
table 3) enables us to apply the above mentioned correction
methods for partial verification, under the assumption that,
conditional on the index test result, the decision to verify is a
random process.
The corrected values of sensitivity and specificity clearly show
the consequences of differential verification (table 4, second
row). We found differences in the estimates of EET accuracy
when verification bias is simply ignored and when it is adjusted
for. The negative predictive value (the item of primary interest,
to rule out elbow fractures), with respect to radiography alone
was lower than the value reported by the authors and fell below
the desired value of ≥97%. This clearly shows that two reference
tests should not be viewed as one.
(For a more detailed discussion of this example and the
possibilities to correct for differential verification, see de Groot
et al, 201126)
Further corrections for differential verification
bias
Recently, a Bayesian method was proposed for simultaneously
adjusting for differential verification bias and for the fact that
these multiple reference tests were imperfect.26 The method
produces accuracy measures both with respect to the latent
disease status and with respect to the use of different reference
tests. The former can be considered as a more general measure
of performance of the index test with respect to a theoretically
defined target condition or disease status since none of the
reference tests used is considered perfect. However, the index
test’s accuracy measures for each of the reference standards
may be considered of greater clinical relevance, as these reflect
the accuracy against the reference tests that are commonly also
performed in daily practice, and on which patient management
decisions will often be based.
Conclusion
In diagnostic accuracy studies, all efforts should be made to
verify as many test results as possible, preferably all, with the
optimal reference test to avoid bias. In practice, the burden on
patients, costs, or other reasons often prevent this from
happening (table 1).27
If test outcome is verified by the reference test for only some
of the patients, which is usually selective disease verification
based on other observed patient information, we advise the use
of the mathematical correction methods described above.16 17 19
There is insufficient knowledge to make general statements
about what proportion of missing reference standard results
might be acceptable and at which point correction methods will
become unreliable. Following various statistical
guidelines,18-21 28 29we recommend the use of correction methods
even with small rates of missing verification data. Even small
proportions of missing outcomes may yield biased accuracy
estimates of the index test(s) or model under study if the
non-verified sample is highly selective.
What upper limits of missing reference test data can still be
corrected for is even harder to say.4 Recently Janssen et al
showed that, even for large amounts of missing data, imputation
leads to less biased results than simply ignoring the (selectively)
non-measured subjects.28 The authors warn that this possibility
for imputation depends on how selective or different the
observed and non-observed subjects are and how many results
remain to build “good enough” imputation models. In any case,
authors applying correction or imputation methods for
addressing partial verification should provide insight in both
issues—how many subjects had missing reference test values
and how different were the verified and non-verified patients
by comparing both groups on their observed characteristics.29 30
If the preferred reference test is not possible and thus missing
in complete subgroups, applying a different, usually inferior,
reference test will obviously produce different information about
the disease status. In such cases, the results should be reported
separately for each reference test to provide more clinically
informative and unbiased measures of diagnostic accuracy.3 If
in these situations one still wants to quantify the accuracy of
the diagnostic index test or model with regard to the same
underlying target condition, one should also correct for possible
imperfections of the applied reference tests.26
Contributors: KGMM is guarantor for the article and heads a
research team aimed at improving methods for quantification
of the diagnostic and prognostic value of medical tests,
biomarkers, and other devices. KJMJ and JAHdG are clinical
epidemiologists in his team. PMMBand JBR lead the Biomarker
and Test Evaluation (BiTE) programme to develop and appraise
methods for evaluating medical tests and biomarkers, and
spearheaded the STARD initiative to improve the reporting of
diagnostic accuracy studies. AWSR’s PhD thesis was on sources
of bias and variation in diagnostic accuracy studies and she
currently works to update QUADAS, a tool for the quality
assessment of studies of diagnostic accuracy included in
systematic reviews. ND is engaged in research in the area of
methods for diagnostic studies.
Reprints: http://journals.bmj.com/cgi/reprintform Subscribe: http://resources.bmj.com/bmj/subscribers/how-to-subscribe
BMJ 2011;343:d4770 doi: 10.1136/bmj.d4770 Page 3 of 9
RESEARCH METHODS & REPORTING
Summary points
In studies of diagnostic accuracy studies, ideally all patients undergoing the index test are verified by the reference
standard
This is not always possible, and incomplete or improper disease verification is one of the major sources of bias in
diagnostic accuracy studies
Partial verification bias occurs when not all patients are verified by the reference standard; instead, disease verification
is related to other, previous (index) test results or patient characteristics. Multiple imputation methods can be used to
correct for the partial verification bias
An alternative reference test may be used for those cases where verification with the preferred reference test is not
possible. This can result in differential verification bias if the results of both reference tests are treated as equal and
interchangeable, when they are really of different quality or define the target condition differently. Instead, the estimated
accuracy of the diagnostic index test should be reported separately for each reference test
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In diagnostic accuracy studies the ability of a test or combination of
tests to correctly identify patients with or without the target condition is
verified by applying a reference standard in all patients who have
undergone the index test. Incomplete or improper disease verification
is one of the major sources of bias in diagnostic accuracy studies. This
study describes the various types of disease verification problems,
including empirical examples, and proposes solutions to alleviate the
ass
ociated biases
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Tables
Table 1| Examples of diagnostic accuracy studies with problems in disease verification
StudyProblemReference standardTarget conditionIndex test(s)
Partial verification
Lee 20016Only PET hotspots were (can be) biopsiedHistology of biopsyDistant metastasesPositron emission tomography
(PET)
Pode 1995754/145 men not verified for unknown
reasons
Combination of transrectal
ultrasound plus biopsy
Prostate cancerDigital rectal examination and
prostate specific antigen
Elhendy 19988Only a small sample of patients verified
because of clinicians’ decision
Coronary angiographyCoronary artery diseaseDobutamine-atropine stress
echocardiography
Kline 2001939% of index test positives and 63% of test
negatives not verified for unspecified
reasons
Liver biopsy with pathologyLiver cancerHepatic scintigraphy
Drum 197210Not all patients verified for unspecified
reasons
Pulmonary angiographyPulmonary embolismD-dimer and alveolar dead space
measurement
Differential verification
Appelboam 200811Index test positives received radiography,
index test negatives received follow-up
Radiography or follow-upElbow fractureElbow extension test
Buller 200912Patients with negative D-dimer test or
clinically low risk of DVT were verified by
follow-up at 3 months
Ultrasonography of the legsDeep vein thrombosis
(DVT)
D-dimer test
Bleeker 200113Mixture of reference standards, as used in
clinical practice
Cultures of blood, spinal fluid,
urine, stools, or a panel diagnosis
Serious bacterial infectionPatient history, physical
examination, and laboratory tests
PIOPED Investigators
199014
Mixture of reference standards, as used in
clinical practice
Scintigraphy, pulmonary
angiography, or follow-up
Acute pulmonary
embolism
Ventilation/perfusion lung scans
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Table 2| Effect of differential disease verification in a diagnostic accuracy study. If the preferred reference test (R) is used only to verify
positive index test results while an alternative reference test (S) is used to validate index test negatives, simply combining the results
ignores the fact that both reference tests have different abilities to determine disease presence or absence, and so the disease status is
ambiguously defined
Reference test results
Index test result
Differential verification with eitherVerification with test SVerification with test R
−ve?+ve?−ve+ve−ve+ve
ba≠——+ba+ve
dcdc——−ve
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Table 3| Distribution of patients in study of diagnostic accuracy of elbow extension test (EET) verified against radiography (for positive
EET) or clinical follow-up (for negative EET)*
Follow-upRadiography
No fractureFractureNo fractureFracture
NANA617521Positive EET
4143167†14†Negative EET
*Data from Appelboam et al, 2008.11
†Data available as a result of protocol violations.
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Table 4| Sensitivity, specificity, and predictive values of elbow extension test* depending on whether correction was made for differential
verification. All values are percentages (95% confidence intervals)
Positive predictive valueNegative predictive valueSpecificitySensitivityAnalysis
45.8 (42.9 to 48.7)97.2 (95.5 to 98.3)48.5 (45.6 to 51.4)96.8 (95.0 to 98.2)No correction
45.8 (42.6 to 49.0)92.3 (88.6 to 95.9)47.2 (44.2 to 50.2)91.8 (88.0 to 95.7)Correction†
*Data from Appelboam et al, 2008.11
†Corrected for partial verification (accuracy with respect to radiography) by method of Begg and Greenes, 1983.16
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Figure
Diagnostic accuracy studies with (a) complete verification by the same reference standard, (b) partial verification, or
(c)differential verification
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